WASHINGTON – A new $56,000-a-year Alzheimer’s drug would raise Medicare premiums broadly, and some patients who are prescribed the medication could face copayments of about $11,500 annually, according to a research report published last week.
Copays for new Alzheimer's drug could be 11K
![](https://statesboroherald.cdn-anvilcms.net/media/images/2021/06/17/images/Drug_1.max-1200x675.jpg)
![This image provided by Biogen shows a vial and packaging for the drug Aduhelm.](https://statesboroherald.cdn-anvilcms.net/media/images/2021/06/17/images/Drug_1.max-752x423.jpg)
Sign up for the Herald's free e-newsletter